JP2021507687A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021507687A5 JP2021507687A5 JP2020529431A JP2020529431A JP2021507687A5 JP 2021507687 A5 JP2021507687 A5 JP 2021507687A5 JP 2020529431 A JP2020529431 A JP 2020529431A JP 2020529431 A JP2020529431 A JP 2020529431A JP 2021507687 A5 JP2021507687 A5 JP 2021507687A5
- Authority
- JP
- Japan
- Prior art keywords
- raav
- cells
- hnaglu
- suspension
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 11
- 239000000725 suspension Substances 0.000 claims 9
- 239000013598 vector Substances 0.000 claims 8
- 108091026890 Coding region Proteins 0.000 claims 4
- 208000036632 Brain mass Diseases 0.000 claims 3
- 208000005392 Spasm Diseases 0.000 claims 3
- 206010044565 Tremor Diseases 0.000 claims 3
- 210000000234 capsid Anatomy 0.000 claims 3
- 238000002641 enzyme replacement therapy Methods 0.000 claims 3
- 208000005340 mucopolysaccharidosis III Diseases 0.000 claims 3
- 239000013612 plasmid Substances 0.000 claims 3
- 241000124740 Bocaparvovirus Species 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 238000011260 co-administration Methods 0.000 claims 2
- 210000005260 human cell Anatomy 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 150000007523 nucleic acids Chemical group 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 230000004393 visual impairment Effects 0.000 claims 2
- 239000013607 AAV vector Substances 0.000 claims 1
- 241000202702 Adeno-associated virus - 3 Species 0.000 claims 1
- 241001634120 Adeno-associated virus - 5 Species 0.000 claims 1
- 102100034561 Alpha-N-acetylglucosaminidase Human genes 0.000 claims 1
- 241000702421 Dependoparvovirus Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 claims 1
- 101000924350 Homo sapiens Alpha-N-acetylglucosaminidase Proteins 0.000 claims 1
- 241000713666 Lentivirus Species 0.000 claims 1
- 208000002678 Mucopolysaccharidoses Diseases 0.000 claims 1
- 241000700584 Simplexvirus Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 108010009380 alpha-N-acetyl-D-glucosaminidase Proteins 0.000 claims 1
- 239000000090 biomarker Substances 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 239000000562 conjugate Substances 0.000 claims 1
- 210000004748 cultured cell Anatomy 0.000 claims 1
- 239000000412 dendrimer Substances 0.000 claims 1
- 229920000736 dendritic polymer Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 230000005021 gait Effects 0.000 claims 1
- 210000003494 hepatocyte Anatomy 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000007914 intraventricular administration Methods 0.000 claims 1
- 239000002479 lipoplex Substances 0.000 claims 1
- 239000002122 magnetic nanoparticle Substances 0.000 claims 1
- 239000006249 magnetic particle Substances 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 206010028093 mucopolysaccharidosis Diseases 0.000 claims 1
- 210000004498 neuroglial cell Anatomy 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- 229920000575 polymersome Polymers 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 238000011272 standard treatment Methods 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 210000002330 subarachnoid space Anatomy 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 210000005253 yeast cell Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762593090P | 2017-11-30 | 2017-11-30 | |
| US62/593,090 | 2017-11-30 | ||
| PCT/US2018/063166 WO2019108856A1 (en) | 2017-11-30 | 2018-11-29 | Gene therapy for mucopolysaccharidosis iiib |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021507687A JP2021507687A (ja) | 2021-02-25 |
| JP2021507687A5 true JP2021507687A5 (https=) | 2022-01-06 |
| JP7384797B2 JP7384797B2 (ja) | 2023-11-21 |
Family
ID=66665818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020529431A Active JP7384797B2 (ja) | 2017-11-30 | 2018-11-29 | ムコ多糖症ｉｉｉｂ型のための遺伝子療法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11723989B2 (https=) |
| EP (1) | EP3717652A4 (https=) |
| JP (1) | JP7384797B2 (https=) |
| KR (1) | KR20200104864A (https=) |
| CN (1) | CN111989396A (https=) |
| AU (1) | AU2018375163A1 (https=) |
| BR (1) | BR112020010977A2 (https=) |
| CA (1) | CA3083761A1 (https=) |
| CL (1) | CL2020001428A1 (https=) |
| EA (1) | EA202091352A1 (https=) |
| IL (1) | IL274972A (https=) |
| MX (1) | MX2020005673A (https=) |
| SG (1) | SG11202004991SA (https=) |
| WO (1) | WO2019108856A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130039888A1 (en) | 2011-06-08 | 2013-02-14 | Nationwide Children's Hospital Inc. | Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders |
| US12605465B2 (en) | 2020-03-23 | 2026-04-21 | The University Of North Carolina At Chapel Hill | AAV-NAGLU vectors for treatment of mucopolysaccharidosis IIIB |
| US20230183741A1 (en) * | 2020-05-11 | 2023-06-15 | University Of Florida Research Foundation, Incorporated | Disease correction by delivery of aav8 vectors expressing codon optimized naglu |
| MX2022014258A (es) | 2020-05-12 | 2023-02-22 | Univ Pennsylvania | Composiciones para la reducción específica de un fármaco de la expresión de transgén. |
| CN111718947B (zh) * | 2020-06-18 | 2022-08-23 | 舒泰神（北京）生物制药股份有限公司 | 用于治疗ⅲa或ⅲb型粘多糖贮积症的腺相关病毒载体及用途 |
| WO2022165313A1 (en) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| EP4288115A4 (en) * | 2021-02-08 | 2025-06-18 | Flagship Pioneering Innovations V, Inc. | Hybrid aav-anellovectors |
| WO2023077133A2 (en) * | 2021-10-29 | 2023-05-04 | The Johns Hopkins University | Controlling homeostatic regulatory circuitry in hypothalamus |
| US20250295807A1 (en) | 2021-11-15 | 2025-09-25 | The Trustees Of The University Of Pennsylvania | Compositions for drg-specific reduction of transgene expression |
| WO2024258961A1 (en) | 2023-06-12 | 2024-12-19 | The Trustees Of The University Of Pennsylvania | Aav gene therapy for mucopolysaccharidosis iiib |
| WO2025157848A1 (en) * | 2024-01-23 | 2025-07-31 | Institut National de la Santé et de la Recherche Médicale | Methods for the intravenous treatment of sanfilippo syndrome type iiib |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5786464C1 (en) | 1994-09-19 | 2012-04-24 | Gen Hospital Corp | Overexpression of mammalian and viral proteins |
| CA2379166C (en) | 1999-08-09 | 2013-03-26 | Targeted Genetics Corporation | Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs |
| MX359371B (es) | 2001-11-13 | 2018-09-25 | Univ Pennsylvania | Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo. |
| PT1453547T (pt) | 2001-12-17 | 2016-12-28 | Univ Pennsylvania | Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas |
| EP2345731B1 (en) | 2003-09-30 | 2015-10-21 | The Trustees of the University of Pennsylvania | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| ES2525067T3 (es) | 2005-04-07 | 2014-12-17 | The Trustees Of The University Of Pennsylvania | Método de incremento de la función de un vector de AAV |
| JP4495210B2 (ja) | 2005-06-09 | 2010-06-30 | パナソニック株式会社 | 振幅誤差補償装置及び直交度誤差補償装置 |
| US7588772B2 (en) | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| WO2009131698A2 (en) * | 2008-04-23 | 2009-10-29 | Iowa State University Research Foundation, Inc. | PHOSPHORYLATED RECOMBINANT N-ACETYL-alpha-D- GLUCOSAMINIDASE (NaGlu) AND USES THEREOF |
| EP3269395A1 (en) | 2008-11-07 | 2018-01-17 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
| WO2011126808A2 (en) | 2010-03-29 | 2011-10-13 | The Trustees Of The University Of Pennsylvania | Pharmacologically induced transgene ablation system |
| EP2561073B1 (en) | 2010-04-23 | 2016-08-24 | University of Massachusetts | Cns targeting aav vectors and methods of use thereof |
| US8927514B2 (en) | 2010-04-30 | 2015-01-06 | City Of Hope | Recombinant adeno-associated vectors for targeted treatment |
| EP2394667A1 (en) * | 2010-06-10 | 2011-12-14 | Laboratorios Del Dr. Esteve, S.A. | Vectors and sequences for the treatment of diseases |
| US8775146B2 (en) * | 2010-07-22 | 2014-07-08 | Shire Human Genetic Therapies, Inc. | Crystal structure of human alpha-N-acetylglucosaminidase |
| US20130039888A1 (en) * | 2011-06-08 | 2013-02-14 | Nationwide Children's Hospital Inc. | Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders |
| RU2013154295A (ru) | 2011-06-08 | 2015-07-20 | Шир Хьюман Дженетик Терапис, Инк. | КОМПОЗИЦИИ ЛИПИДНЫХ НАНОЧАСТИЦ И СПОСОБЫ ДЛЯ ДОСТАВКИ мРНК |
| US20150126589A1 (en) | 2012-06-08 | 2015-05-07 | Ethris Gmbh | Pulmonary Delivery of Messenger RNA |
| WO2014125647A1 (ja) | 2013-02-18 | 2014-08-21 | 富士通オプティカルコンポーネンツ株式会社 | 光受信装置 |
| AU2014235096B2 (en) | 2013-03-15 | 2020-03-19 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treating MPSI |
| ES2739288T3 (es) | 2013-09-13 | 2020-01-30 | California Inst Of Techn | Recuperación selectiva |
| CA2947468C (en) * | 2014-05-14 | 2022-10-25 | Laboratorios Del Dr. Esteve S.A. | Adenoassociated virus vectors for the treatment of lysosomal storage disorders |
| AU2015320694B2 (en) | 2014-09-24 | 2021-11-11 | City Of Hope | Adeno-associated virus vector variants for high efficiency genome editing and methods thereof |
| HK1256341A1 (zh) | 2015-05-15 | 2019-09-20 | 明尼苏达大学董事会 | 用於治疗性递送到中枢神经系统的腺相关物 |
| AU2016366560A1 (en) | 2015-12-11 | 2018-06-28 | The Trustees Of The University Of Pennsylvania | Gene therapy for treating familial hypercholesterolemia |
| EP3387138B1 (en) | 2015-12-11 | 2022-01-26 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav9 |
| US20190083583A1 (en) | 2016-01-29 | 2019-03-21 | Alexion Pharmaceuticals, Inc. | Enzyme replacement therapy in mucopolysaccharidosis iiib patients |
| CA3012195A1 (en) | 2016-02-03 | 2017-08-10 | The Trustees Of The University Of Pennsylvania | Gene therapy for treating mucopolysaccharidosis type i |
| WO2017136533A1 (en) | 2016-02-03 | 2017-08-10 | The Trustees Of The University Of Pennsylvania | Methods for treating diagnosing, and monitoring treatment of mucopolysaccharidoses |
| PT3589730T (pt) | 2017-02-28 | 2024-02-28 | Univ Pennsylvania | Vetor de vírus adenoassociado (aav) de clado f e suas utilizações |
-
2018
- 2018-11-29 CN CN201880088240.8A patent/CN111989396A/zh active Pending
- 2018-11-29 MX MX2020005673A patent/MX2020005673A/es unknown
- 2018-11-29 EP EP18882454.4A patent/EP3717652A4/en not_active Withdrawn
- 2018-11-29 CA CA3083761A patent/CA3083761A1/en active Pending
- 2018-11-29 WO PCT/US2018/063166 patent/WO2019108856A1/en not_active Ceased
- 2018-11-29 BR BR112020010977-0A patent/BR112020010977A2/pt not_active Application Discontinuation
- 2018-11-29 EA EA202091352A patent/EA202091352A1/ru unknown
- 2018-11-29 SG SG11202004991SA patent/SG11202004991SA/en unknown
- 2018-11-29 AU AU2018375163A patent/AU2018375163A1/en not_active Abandoned
- 2018-11-29 JP JP2020529431A patent/JP7384797B2/ja active Active
- 2018-11-29 US US16/768,547 patent/US11723989B2/en active Active
- 2018-11-29 KR KR1020207018109A patent/KR20200104864A/ko not_active Withdrawn
-
2020
- 2020-05-27 IL IL274972A patent/IL274972A/en unknown
- 2020-05-28 CL CL2020001428A patent/CL2020001428A1/es unknown
-
2023
- 2023-07-10 US US18/349,277 patent/US20240009327A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021507687A5 (https=) | ||
| JP7607007B2 (ja) | 変異ａａｖ、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法 | |
| JP2021508241A5 (https=) | ||
| JP7585233B2 (ja) | ポンペ病の治療のために有用な組成物 | |
| US10413598B2 (en) | Factor IX gene therapy | |
| JP2019506445A (ja) | パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質 | |
| JP2022531809A (ja) | ＡＴＰａｓｅ媒介性疾患の処置のための組成物および方法 | |
| US20230045478A1 (en) | Liver-specific promoter and application thereof | |
| US20240343768A1 (en) | Gene therapy for tuberous sclerosis | |
| CN116096904A (zh) | 改进的aav-abcd1构建体和用于治疗或预防肾上腺脑白质营养不良(ald)和/或肾上腺脊髓神经病(amn)的用途 | |
| KR20250102136A (ko) | 중추 신경계에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법 | |
| JP2021520811A (ja) | ヘキソサミニダーゼアルファおよびベータサブユニットをコードしているバイシストロニックａａｖベクターならびにその使用 | |
| WO2020236352A1 (en) | Optimized gene therapy targeting retinal cells | |
| US20240335506A1 (en) | Aqp1 gene therapy to prevent radiation induced salivary hypofunction | |
| KR20260045798A (ko) | 증가된 뇌 풍부화를 갖는 아데노-연관 바이러스 조성물 | |
| JP2025509193A (ja) | Ｇｌｐ－２受容体アゴニスト融合物をコードするウイルスベクター及び短腸症候群の治療におけるその使用 | |
| CA3146364A1 (en) | One-step gene therapy for duchenne muscular dystrophy via gene replacement and anti-inflammation | |
| US20240425879A1 (en) | Compositions and methods for adeno-associated (aav) virus dnase expression | |
| JP2024506860A (ja) | ニーマンピック病ａ型を治療するための組成物及び方法 | |
| WO2025157137A1 (zh) | Aav载体、载体组合物、嵌合载体和治疗或预防sma的方法 | |
| WO2023147304A1 (en) | Aav capsids for improved heart transduction and detargeting of liver | |
| EA052984B1 (ru) | Генотерапия aqp1 для предупреждения гипофункции слюнной железы, вызываемой облучением | |
| CA2978917A1 (en) | Recombinant glut1 adeno-associated viral vector constructs and related methods for restoring glut1 expression |